BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26017039)

  • 1. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    Garnaud C; Botterel F; Sertour N; Bougnoux ME; Dannaoui E; Larrat S; Hennequin C; Guinea J; Cornet M; Maubon D
    J Antimicrob Chemother; 2015 Sep; 70(9):2556-65. PubMed ID: 26017039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.
    Spettel K; Barousch W; Makristathis A; Zeller I; Nehr M; Selitsch B; Lackner M; Rath PM; Steinmann J; Willinger B
    PLoS One; 2019; 14(1):e0210397. PubMed ID: 30629653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.
    Imbert S; Castain L; Pons A; Jacob S; Meyer I; Palous M; Vezinet C; Langeron O; Hennequin C; Monsel A; Fekkar A
    Clin Microbiol Infect; 2016 Oct; 22(10):891.e5-891.e8. PubMed ID: 27484020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    Xisto MI; Caramalho RD; Rocha DA; Ferreira-Pereira A; Sartori B; Barreto-Bergter E; Junqueira ML; Lass-Flörl C; Lackner M
    J Antimicrob Chemother; 2017 Apr; 72(4):988-992. PubMed ID: 28065893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins.
    Chassot F; Venturini TP; Piasentin FB; Rossato L; Fiorini A; Svidzinski TI; Alves SH
    Mycopathologia; 2016 Oct; 181(9-10):663-70. PubMed ID: 27318852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
    Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.